More on LYEL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.6 Score)

Upcoming Events

- Earnings (11/5/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lyell Immunopharma (NQ:LYEL)
Delayed: 12.57 -2.32 (15.58%)
Prev. Close $14.89  
Open$14.87 
52 Wk High$ 
52 Wk Low$ 
Day High$14.87 
Day Low$12.34 
P/E N/A  
EPS$ 
Volume413,026 

Friends, Peers and Foes (?): CRBU, GTBP, NRIX, SLS PRQR (more...)

Jun 3, 2026 06:55 AM H.C. Wainwright Reiterates Buy Rating on Lyell Immunopharma (LYEL)
Jun 1, 2026 08:00 AM Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
May 15, 2026 04:08 PM Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
May 12, 2026 08:00 AM Lyell Immunopharma Announces Participation in May Investor Conferences
May 11, 2026 11:12 AM Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: MWG Caph Ltd
May 8, 2026 04:24 PM Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Explore Investments LLC/DE
May 6, 2026 04:15 PM Form 10-Q Lyell Immunopharma, Inc. For: Mar 31
May 6, 2026 04:12 PM Form 8-K Lyell Immunopharma, Inc. For: May 06
May 6, 2026 04:05 PM Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
May 1, 2026 05:29 AM BofA Securities Reiterates Underperform Rating on Lyell Immunopharma (LYEL), PT $12, 'we continue to view the story cautiously'
View All Articles

Entities mentioned with LYEL

View All Entities